Seeing Is Believing
Currently out of the existing stock ratings of Brandon Folkes, 102 are a BUY (86.44%), 1 are a SELL (0.85%), 15 are a HOLD (12.71%).
Analyst Brandon Folkes, currently employed at CIBC, carries an average stock price target met ratio of 34.31% that have a potential upside of 21.1% achieved within 221 days.
Brandon Folkes’s has documented 233 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRTX, Heron Therapeuti at 09-Jun-2025.
Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for OMER (OMEROS) at 11/14/2024. The price target of $9 was fulfilled within 8 days with a profit of $2.05 (29.5%) receiving and performance score of 36.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6
$0.41 (7.33%)
$8
3 years 4 months 1 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Hold
$5
$-0.59 (-10.55%)
3 years 4 months 12 days ago
(14-Feb-2022)
0/1 (0%)
$-0.56 (-10.07%)
Hold
$4.5
$-1.09 (-19.50%)
3 years 5 months 5 days ago
(21-Jan-2022)
4/4 (100%)
$1.14 (33.93%)
167
Buy
$6.25
$0.66 (11.81%)
$5
4 years 1 months 20 days ago
(06-May-2021)
1/2 (50%)
$3.07 (96.54%)
287
Buy
$8
$2.41 (43.11%)
5 years 7 months 13 days ago
(13-Nov-2019)
1/2 (50%)
$2.26 (36.00%)
1683
Which stock is Brandon Folkes is most bullish on?
What Year was the first public recommendation made by Brandon Folkes?